Kumar Dhanasekharan
Chief Tech/Sci/R&D Officer presso RENOVACOR, INC.
Profilo
Kumar Dhanasekharan is currently the Senior Vice President-Technical Operations at Renovacor, Inc. Previously, he worked as the Vice President-Technical Operations at SwanBio Therapeutics, Inc. He completed his undergraduate degree at the Indian Institute of Technology Madras and his doctorate at Rutgers University, Camden.
Posizioni attive di Kumar Dhanasekharan
Società | Posizione | Inizio |
---|---|---|
RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 04/10/2021 |
Precedenti posizioni note di Kumar Dhanasekharan
Società | Posizione | Fine |
---|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Corporate Officer/Principal | - |
Formazione di Kumar Dhanasekharan
Indian Institute of Technology Madras | Undergraduate Degree |
Rutgers University, Camden | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Kumar Dhanasekharan